Pills by jugaad: Excerpts from Bottle of Lies
A new investigative book, Bottle of Lies, says that Indian cancer drugs are contaminated; cholesterol medication has shards of glass; and, blood …
Colour code for generic medicines a no-brainer
There are a number of systemic gaps without addressing which the government’s latest plan for the pharma sector won’t work
A Patient's Dilemma
Doctors continue to push for branded medications, after the government's launch of an affordable medicine campaign, at the expense of their …
Government stand against EU ban on Indian drugs much needed, says industry
Standing against the arbitrary ban on 700 drugs, India has decided to defer the proposed talks on the free trade agreement between India and the EU
When generics turn into Big Pharma
Top generics firms, some from India, are charged with price-fixing and sleazy deals; Sun Pharma has paid up to settle claims
Six reasons why antibiotics access remains a challenge in Uganda
Lack of registry, sub-standard health facilities, poor cold storage, limited expenditure on health, irrational antibiotic use and lack of …
Activists demand compulsory licence for another life-saving cancer drug
Appellate board's order upholding Natco's CL for sorafenib tosylate may pave way for manufacture of generic version of other patented drugs
The NATCO CL fallout
The compulsory licence granted to Natco may not be a trendsetter but it will shake up the pharmaceuticals market
EU fines nine pharma companies for violating competition rules
Lundbeck pharma made other companies enter market late with generic versions of its drug citalopram
European Parliament rejects Anti-Counterfeiting Trade Agreement
Act makes it possible to seize and destroy even legitimately produced generic drugs exported from India to poor countries
US keeps India out of Priority Foreign Country list of 'worst IP offenders'
US Trade Representative’s Special 301 Report keeps up pressure on India to fall in line with US’ interests
Substantiate allegations against Ranbaxy, says Supreme Court
Experts say allegations against the generic pharma company motivated by vested interests
‘PESTICIDES’ IN DRUGS
Sharad Pawar’s provision for protecting test data in the Pesticides Bill could spill over into trade agreements and hit the drugs industry, too
Novartis loses patent appeal in landmark suit
Supreme Court upholds amended law that bars patents for insignificant improvements to an existing drug—in this case anti-cancer drug …
Look back at the decade: Generic drugs
Fifteen years after it rose and went limp, the biotech sector saw a bull run of sorts
COVID-19 also brings focus back on pollution due to pharmaceuticals
No time for quick-fix measures. India needs stricter laws
Pills for polls
The free medicine scheme in Rajasthan may benefit Congress
Vidarbha gets its first generic medicines shop
Challenge to popularising these stores is to get doctors to prescribe low-cost generic drugs